tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katherine Breedis, 8 are a BUY (100%).
Analyst Katherine Breedis works with a stock forecast success ratio of 25% fulfilled within 1058.5 days on average. Previously, Katherine Breedis worked at STIFEL.
Katherine Breedis’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VYGR, Voyager Therapeutics at 28-Jul-2017.
Analyst best performing recommendations are on GILD (GILEAD SCIENCES).
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
105
$37.92 (56.53%)
105
8 days ago
4/12 (33.33%)
$38.24 (57.28%)
1249
Hold
75
$7.92 (11.81%)
85
10 days ago
4/7 (57.14%)
$8.07 (12.06%)
107
Hold
78
$10.92 (16.28%)
84
1 months 23 days ago
11/14 (78.57%)
$5.75 (7.96%)
575
Hold
82
$14.92 (22.24%)
91
2 months 5 days ago
21/34 (61.76%)
$9.22 (12.67%)
633
Buy
90
$22.92 (34.17%)
101
2 months 5 days ago
8/12 (66.67%)
$17.22 (23.66%)
792
What Year was the first public recommendation made by Katherine Breedis?
